CAPTRUST Financial Advisors
SMTI icon

CAPTRUST Financial Advisors’s Sanara MedTech SMTI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,768
Closed -$438K – 2175
2022
Q3 		$438K Hold
14,768
– – ﹤0.01% 1310
2022
Q2 		$308K Hold
14,768
– – ﹤0.01% 1415
2022
Q1 		$421K Hold
14,768
– – ﹤0.01% 1226
2021
Q4 		$436K Buy
+14,768
New +$465K ﹤0.01% 1187

Other funds holding SMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

CAPTRUST Financial Advisors's SMTI Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Sanara MedTech (SMTI) in Q4 2022, closing a stake of 14,768 shares — an estimated $438K sold.

CAPTRUST Financial Advisors first reported a position in SMTI in Q4 2021 and held it in 4 quarters. The position peaked at $438K in Q3 2022. 31 funds tracked by Wall St. Rank hold SMTI as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Sanara MedTech position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 14,768 Sanara MedTech shares in Q4 2022, an estimated $438K.
  • CAPTRUST Financial Advisors first reported a position in Sanara MedTech in Q4 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Sanara MedTech position peaked at $438K in Q3 2022.
  • 31 funds tracked by Wall St. Rank held Sanara MedTech as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.